OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair
Karen W. Gripp, Kimberly A. Aldinger, James T. Bennett, et al.
American Journal of Medical Genetics Part A (2016) Vol. 170, Iss. 9, pp. 2237-2247
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

RAS Proteins and Their Regulators in Human Disease
Dhirendra K. Simanshu, Dwight V. Nissley, Frank McCormick
Cell (2017) Vol. 170, Iss. 1, pp. 17-33
Open Access | Times Cited: 1576

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
Matthew Clarke, Alan Mackay, Britta Ismer, et al.
Cancer Discovery (2020) Vol. 10, Iss. 7, pp. 942-963
Open Access | Times Cited: 209

The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway
Mylène Tajan, Romain Paccoud, Sophie Branka, et al.
Endocrine Reviews (2018) Vol. 39, Iss. 5, pp. 676-700
Open Access | Times Cited: 196

Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk
Anita Villani, Mary‐Louise C. Greer, Jennifer M. Kalish, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 12, pp. e83-e90
Open Access | Times Cited: 144

LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases
Taiki Abe, Ikumi Umeki, Shin‐ichiro Kanno, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 3, pp. 1023-1035
Open Access | Times Cited: 101

Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers
Rita Sulahian, Jason J. Kwon, Katherine H. Walsh, et al.
Cell Reports (2019) Vol. 29, Iss. 1, pp. 118-134.e8
Open Access | Times Cited: 79

The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases
Liang Qu, Chao Pan, Shiming He, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 76

Structure–function analysis of the SHOC2–MRAS–PP1C holophosphatase complex
Jason J. Kwon, Behnoush Hajian, Yuemin Bian, et al.
Nature (2022) Vol. 609, Iss. 7926, pp. 408-415
Open Access | Times Cited: 58

Clinical overview on RASopathies
Martin Zenker
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 414-424
Open Access | Times Cited: 51

The molecular genetics of RASopathies: An update on novel disease genes and new disorders
Marco Tartaglia, Yoko Aoki, Bruce D. Gelb
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 425-439
Open Access | Times Cited: 43

Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy
Erin M. Higgins, J. Martijn Bos, Heather Mason‐Suares, et al.
JCI Insight (2017) Vol. 2, Iss. 5
Open Access | Times Cited: 83

SHOC2–MRAS–PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis
Lucy C. Young, Nicole Hartig, Isabel Boned del Río, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 45
Open Access | Times Cited: 76

Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1–PPP1CB complexes
Ikumi Umeki, Tetsuya Niihori, Taiki Abe, et al.
Human Genetics (2018) Vol. 138, Iss. 1, pp. 21-35
Closed Access | Times Cited: 71

SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers
Greg G. Jones, Isabel Boned del Río, Sibel Sarı, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 68

Intronic CRISPR Repair in a Preclinical Model of Noonan Syndrome–Associated Cardiomyopathy
Ulrich Hanses, Mandy Kleinsorge, Lennart Roos, et al.
Circulation (2020) Vol. 142, Iss. 11, pp. 1059-1076
Open Access | Times Cited: 66

Clinical Presentation and Natural History of Hypertrophic Cardiomyopathy in RASopathies
Giulio Calcagni, Rachele Adorisio, Simone Martinelli, et al.
Heart Failure Clinics (2018) Vol. 14, Iss. 2, pp. 225-235
Closed Access | Times Cited: 64

Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome
Yline Capri, Elisabetta Flex, Oliver H.F. Krumbach, et al.
The American Journal of Human Genetics (2019) Vol. 104, Iss. 6, pp. 1223-1232
Open Access | Times Cited: 64

Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations
Jeevana Praharsha Athota, Meenakshi Bhat, Sheela Nampoothiri, et al.
BMC Medical Genetics (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 63

Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts
Victoria Dunnett-Kane, Emma Burkitt‐Wright, Fiona Blackhall, et al.
Annals of Oncology (2020) Vol. 31, Iss. 7, pp. 873-883
Open Access | Times Cited: 53

Structure of the SHOC2–MRAS–PP1C complex provides insights into RAF activation and Noonan syndrome
Daniel A. Bonsor, Patrick Alexander, Kelly Snead, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 10, pp. 966-977
Open Access | Times Cited: 37

Structure of the MRAS–SHOC2–PP1C phosphatase complex
Zachary J. Hauseman, Michelle Fodor, Anxhela Dhembi, et al.
Nature (2022) Vol. 609, Iss. 7926, pp. 416-423
Open Access | Times Cited: 31

Structural basis for SHOC2 modulation of RAS signalling
Nicholas P. D. Liau, Matthew C. Johnson, Saeed Izadi, et al.
Nature (2022) Vol. 609, Iss. 7926, pp. 400-407
Open Access | Times Cited: 30

Cardiovascular disease in Noonan syndrome
Mary Ella Pierpont, M. Cristina Digilio
Current Opinion in Pediatrics (2018) Vol. 30, Iss. 5, pp. 601-608
Closed Access | Times Cited: 59

Germline-Activating RRAS2 Mutations Cause Noonan Syndrome
Tetsuya Niihori, Koki Nagai, Atsushi Fujita, et al.
The American Journal of Human Genetics (2019) Vol. 104, Iss. 6, pp. 1233-1240
Open Access | Times Cited: 51

Regulation of Synaptic Transmission and Plasticity by Protein Phosphatase 1
Karl Foley, Cody McKee, Angus C. Nairn, et al.
Journal of Neuroscience (2021) Vol. 41, Iss. 14, pp. 3040-3050
Open Access | Times Cited: 34

Page 1 - Next Page

Scroll to top